DT MedTech Secures CE Marking and Begins Active Distribution of Hintermann Series H3™ Lower Extremity Medical Devices

DT MedTech, LLC (DTMT) announced today that having secured CE Marking for the Hintermann Series H3 total ankle replacement devices, in compliance with mandatory European Directives, they are now actively selling and distributing their products outside the USA.

The DTMT Hintermann Series products for the lower extremity include: (1) Hintermann Series H3 three-piece Total Ankle Replacement prosthesis, comprising the Standard, Sensitive, and Revision systems (formerly known as the HINTEGRA Total Ankle Replacement prosthesis); (2) Kalix II subtalar arthrodesis implant to treat flatfoot deformities; and (3) instrumentation to support the implantable devices. Developed by prominent surgeon, Prof. Beat Hintermann, this Total Ankle Replacement system is a proven, dominant player in the ankle replacement market outside the USA with over 15 years of solid clinical efficacy.

The Hintermann Series product line has been approved for use in the following countries: Australia, Austria, Belgium, Canada, Costa Rica, Czech Republic, Denmark, Finland, France, Germany, Ireland, Italy, South Korea, Latvia, Lithuania, Luxembourg, Malaysia, Netherlands, New Zealand, Panama, Portugal, Russia, Sweden, Switzerland, Thailand, UAE, and the United Kingdom.

Distribution channels have been secured to handle products in approved countries, with HealthLink Europe BV delivering the majority of logistics outside the USA.

David Reicher, President and Chief Executive Officer of DTMT, stated, “Through hard work and sheer determination, everyone at DT MedTech can finally see the successful results of their efforts. We thank them all.